Why industry leaders are choosing the Simoa planar technology for phase I-IV clinical Studies | Webinar

Access the webinar today!

Follow Us!


Join Dr. Maribeth Raines, Vice President of Laboratory Services at Pacific Biomarkers and Kevin Hrusovsky, CEO and Chairman of Quanterix as they discuss how the next generation Simoa SP-X™ Imaging and Analysis System and CorPlex™ Assays are helping accelerate clinical trials and drug development programs. Dr Raines will share specific examples of how these single- and multiplex assays provide CROs like Pacific Biomarkers with the resources to support Phase I-IV clinical trials more effectively.